No abstract available.
Flow Cytometry* ; Microscopy*

No abstract available.
Flow Cytometry* ; Microscopy*

No abstract available.
DNA* ; Flow Cytometry*

No abstract available.
DNA* ; Flow Cytometry*

No abstract available.
Adenocarcinoma* ; Flow Cytometry*

No abstract available.
Flow Cytometry* ; Microscopy* ; Urinalysis*

No abstract available.
Flow Cytometry* ; Mastocytosis, Systemic* ; Splenomegaly*

In order to meet the needs of the flow cytometry for the simultaneous analysis of multiple fluorescence wavelengths and small volume, the design method of flow cytometry spectrum analysis system is presented by analyzing the characteristics of Dyson structure. And according to the method, a flow cytometry spectrum analysis system is disigned with Dyson type.The system's spectral range is 400 nm to 800 nm, the defocused spot size is less than the pixel size 24μ mm, the ransfer function value is above 0.8 at the Nyquist cut-off frequency 21 lp/mm,the spectral resolution is less than 3 nm, and the overall size is 83.54 mm×85.60 mm.The system has good optical performance and small volume, which meets the needs of the flow cytometry fluorescence spectral analysis. The outstanding innovation of this system is the application of Dyson light splitting structure and EMCCD detector which is high speed and high sensitivity.
Equipment Design ; Flow Cytometry ; instrumentation

Multiple myeloma is a common hematological malignancy which is characterized by plasma cell malignancies proliferation and osteolysis destruction. It manifests M-protein, bone destruction, anemia, renal function impairment and immune function abnormality. In recent years, researchers have known that flow cytometric immunophenotyping is valuable in diagnosis, therapy, prognosis and minimal residual disease detection of multiple myeloma. The review summarizes the development of flow cytometric immunophenotyping in multiple myeloma, including application of flow cytometry in multiple myeloma and immunophenotypic features of flow cytometric analysis in multiple myeloma.
Flow Cytometry ; Humans ; Immunophenotyping ; Multiple Myeloma ; immunology

Prognosis and biologic behavior of malignant ovarian tumors have been assessed by clinical staging, morphological grading and many other variables. Recently DNA ploidy measured by flow cytometry has been suggested as an additional important indicator of the tumor behavior and prognosis. The author measured DNA ploidy, S-phase fraction and DNA Index in 36 patients of epithelial ovarian tumors(17 were malignant, and 19 were borderline) by flow cytometric analysis of paraffin embedded tumor blocks. Comparing with FIGO stage, tumor grade, histologic type and others, the author investigated the clinical significance of the results of flow cytometric analysis. The results obtained as follows : (continue)
DNA* ; Flow Cytometry ; Humans ; Paraffin ; Ploidies* ; Prognosis